Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irinotecan Combined With S-1( IRIS ) Followed by mFOLFOX6 Regimen Versus mFOLFOX6 Followed by IRIS Regimen in Advanced Colorectal Cancer

NCT00316745 is registered in ClinicalTrials.gov with Hokkaido Gastrointestinal Cancer Study Group as lead sponsor.

NCT NCT00316745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irinotecan Combined With S-1( IRIS ) Followed by mFOLFOX6 Regimen Versus mFOLFOX6 Followed by IRIS Regimen in Advanced Colorectal Cancer
Lead sponsor
Hokkaido Gastrointestinal Cancer Study Group
Phase
Phase 3
Overall status
Suspended
Start date
April 30, 2006
Completion date
March 31, 2009
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer